Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Space manufacturing shows potential for next-generation therapies, says GlobalData

The space environment is rapidly emerging as a vital platform for scientific discovery and biomedical advancement. As space becomes more accessible, pharmaceutical and biotech companies are focusing on low-Earth orbit to explore new opportunities in drug development and disease modelling and therapeutic design, according to GlobalData, a leading data and analytics company. Microgravity affects biological […]
Read more

APAC equities steady in 2025 as AI boom and easing trade tensions support market sentiment, says GlobalData

Asia-Pacific equities remained resilient through 2025 as trade uncertainty, political shifts, and the rapid acceleration of artificial intelligence (AI) reshaped regional markets. The standout driver was a strong AI-led rise in technology and semiconductor stocks, helping cushion broader volatility. As 2026 approaches, contrasting monetary paths and renewed tariff risks point to another period of sharp […]
Read more

High-value deals drive venture capital activity amid overall slowdown during Q1-Q3 2025, reveals GlobalData

Global venture capital (VC) activity in Q1-Q3 2025 shows a clear shift in strategy as overall deal volume year-on-year (YoY) declined mainly due to an 11% drop in low-value (≤ $10 million) investments. However, high-value investments (>$100 million) rose 17% and billion-dollar deals volume also increased. This reflects investors’ focus on fewer but stronger opportunities […]
Read more

Magnificent 7 ramp-up R&D and capex as AI shift drives $2 trillion revenue surge, reveals GlobalData

The Magnificent 7—Apple, Microsoft, Alphabet, Amazon, Meta, NVIDIA, and Tesla—ended their latest fiscal year with an unmistakable theme: escalating R&D intensity and capital spending aligned around artificial intelligence (AI), even as cash balances normalize post-COVID-19 pandemic. The group collectively generated over $2.08 trillion in revenue, up about 14% year-on-year (YoY), underscoring the resilience of the […]
Read more

Sutaray NMPA approval marks major milestone in China HER2-positive breast cancer market, says GlobalData

The National Medical Products Administration (NMPA) in China has recently approved Sichuan Kelun Biotech Biopharmaceutical’s Sutaray (trastuzumab botidotin) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer (BC). The move marks a pivotal advance in the nation’s oncology market as domestic innovation accelerates in high-need breast cancer segments, says GlobalData, a […]
Read more

Metsera takeover battle reflects Novo Nordisk and Pfizer push to challenge Lilly’s obesity drug dominance, says GlobalData

Following the news that Novo Nordisk made an unsolicited acquisition bid for US-based obesity biotech Metsera Therapeutics, which was subsequently rejected by Pfizer, but designated by Metsera as a “Superior Company Proposal” to the one previously agreed between Metsera and Pfizer: Jay Patel, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers […]
Read more

Top 20 global biopharmaceutical companies report 4% market capitalization growth in Q3 2025, reveals GlobalData

The top 20 global biopharmaceutical companies experienced mixed individual market capitalization performances in Q3 2025, with those experiencing robust pipeline progress reaping success. This resulted in a 4% quarter-on-quarter (QoQ) increase in their combined market capitalization from $3.7 trillion on 30 June 2025 to $3.8 trillion on 30 September 2025, reveals GlobalData, a leading data […]
Read more

Agentic and GenAI adoption across capital markets rises but financial institutions temper expectations, finds Celent, a GlobalData company

54% of survey respondents expect to have Agentic AI in production next year GenAI sentiment down YoY as industry focuses on ROI Financial institutions across capital markets indicates respondents are taking a reality check when it comes to expectations around GenAI and Agentic AI. While financial institutions quickly implemented the more straight-forward use cases such […]
Read more

Vietnam card payments market to grow by 5% in 2025 to reach $48.7 billion, forecasts GlobalData

The card payments market in Vietnam is expected to grow by 5% to reach VND1.2 quadrillion ($48.7 billion) in 2025, supported by the constant consumer shift towards non-cash payments. While cash remains dominant, strong government support, growing card penetration, and evolving consumer preferences are supporting the country’s transition to a less cash-dependent economy and reshaping […]
Read more

Gen AI and agentic AI drive next stage in trade finance digitization, says Celent, a GlobalData company

Trade finance remains slowed by manual processes, paper documents, and persistent fraud, delaying operations by days and increasing risk. Emerging generative AI (GenAI) and agentic AI applications offer banks an opportunity to digitize critical workflows, improve efficiency, strengthen risk detection, and enhance customer experience, potentially transforming trade finance operations and creating a competitive edge in […]
Read more

Japan ultrasound systems market to reach $1.265 billion in 2034, forecasts GlobalData

Japan’s medical imaging field is progressing steadily with broader adoption of ultrasound diagnostic systems. Within this context, Japan’s ultrasound systems market is projected to reach $1.265 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Ultrasound Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to […]
Read more

Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy, says GlobalData

Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in patients with Staphylococcus aureus bacteremia (SAB) in a Phase IIa trial, reinforcing the growing clinical promise of bacteriophage-based treatments. The findings highlight the therapy’s potential to address antibiotic resistance and provide a new treatment option for patients with serious bloodstream infections, says GlobalData, a leading […]
Read more

Asia-Pacific nuclear imaging agents market set to reach $1,105 million in 2034, forecasts GlobalData

Fueled by an aging population, rising chronic disease burden, and government healthcare investments, the nuclear imaging agents market in the Asia-Pacific region is projected to reach $1,105 million in 2034, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036,” reveals […]
Read more

Agentic AI transforms insurance customer service but human insight remains key, says GlobalData

Agentic AI is reshaping customer service in insurance by enabling real-time, intelligent interactions while working alongside human agents. Although its decision-making abilities make it a powerful support tool, industry experts agree that human oversight remains essential, as customers and insurers alike value the reassurance of a human presence to ensure accuracy, accountability, and trust in […]
Read more

APAC deal landscape shows mixed trends amidst prevailing uncertainties through Q1-Q3 2025, finds GlobalData

The Asia-Pacific (APAC) deal landscape has demonstrated a complex picture in the first three quarters (Q1-Q3) of 2025, with the total number of deals (mergers & acquisitions (M&A), private equity and venture financing) announced in the region experiencing a decline of around 1% year-on-year (YoY). While this downturn reflects a cautious sentiment, certain markets within […]
Read more

GlobalData automotive analysts use AI to guide clients and anticipate market shifts

LONDON, 28 October 2025 – As electrification, regulatory shifts, and evolving consumer expectations continue to redefine the global automotive industry, navigating uncertainty demands both data precision and human insight. GlobalData Plc, the trusted intelligence partner to leading organizations worldwide, empowers clients through its artificial intelligence (AI)-enhanced Automotive Intelligence Solution, where advanced technology amplifies the depth […]
Read more

Cyber insurance demand surges amid heightened geopolitical tensions, reveals GlobalData

Cyber insurance has emerged as the most in-demand insurance product as escalating geopolitical tensions drive a surge in cyber threats. With conflicts increasingly extending into cyberspace, organizations are prioritizing stronger digital resilience, while insurers focus on providing clearer coverage and faster recovery support to meet the growing complexity of cyber-related risks, reveals the latest poll […]
Read more

Australia defense budget poised to grow at 5.9% CAGR between 2026 and 2030, forecasts GlobalData

Amidst escalating tensions in the Indo-Pacific, shifting geopolitical fault lines and growing strategic competition, Australia is accelerating efforts to modernize its military. Against this backdrop, Australia’s defense budget is set to increase at a compound annual growth rate (CAGR) of 5.9% from $44.6 billion in 2026 to $56.2 billion in 2030, driven in large part […]
Read more
1 … 19 20 21 22 23 … 209